Patents, Policy & Guidelines

Oct 22, 2024

Dexmedetomidine ICU

In the context of research impact evaluation, a key pathway to achieving real-world change is the translation of evidence into policy and clinical practice. Our group actively contributes to this process through involvement in the development of clinical guidelines, consensus statements, and policy documents. We bring together methodological expertise, clinical experience, and a global perspective, ensuring that our contributions are both rigorous and relevant.

We have played leadership roles in several national and international initiatives, and our research has been cited in recommendations issued by the World Health Organization, national health ministries, and leading medical societies. These efforts reflect our commitment to advancing science that informs practice and improves health outcomes worldwide.

📚 Our Research Cited in Patents, Policy Documents and Guidelines

Our scientific publications have been cited in several key documents, including (as of September 2026):

10 articles were cited in 31 Patents (source: lens.org)
Our work was cited 206 times in 184 policy documents from governments, intergovernmental organisations and think tanks in more than 20 countries; these documents were themselves cited 784 times in 500 further policy documents (source: Sage Policy Profiles, powered by Overton, September 2026)
24 of our articles were cited in 30 clinical guidelines and official recommendations, including from WHO, ECDC/EMA, ATS/IDSA, ESICM, AWMF (Germany) and NACI (Canada) (sources: Sage Policy Profiles/Overton and PubMed, September 2026)
10 articles were cited in 20 Wikipedia articles in 10 languages, including entries on vaccines, pneumonia and intensive care (source: Wikipedia search by DOI and author name, September 2026)

🧭 Guidelines We’ve Authored or Contributed To

🗂️ Direct Contributions

📄 WHO, Expanding our understanding of Post COVID-19 condition (2021)

Member of the Working Group (WG1), Pathophysiology 📎 See Webinar

📄 Core Outcome Measures for Trials in People With COVID-19 (2021)

Panel member and collaborator, international consensus on core outcomes for COVID-19 trials (respiratory failure, multiorgan failure, shortness of breath and recovery), Critical Care Medicine 📎 View article

📄 ICM Practice Guidelines, Dexmedetomidine (2022)

Rapid Practice Guidelines from the European Society of Intensive Care Medicine (ESICM) 📎 View guideline

📄 Consensus, Global Climate and Health Summit 2025 (2025)

Guiding Principles Consensus Statement, Physiological Society 📎 Read on PhySoc

📄 Conference Reports and Expert Panel, Volume of Resuscitation Fluids (2025)

European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients 📎 View guideline

📄 Conference Reports and Expert Panel, Fluid Removal at De-escalation phase (2025)